Form 8-K INTERPARFUMS INC For: May 05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 Date of Report (Date of Earliest Event Reported): May 5, 2026 

 

Interparfums, Inc.
(Exact name of Registrant as specified in its charter)

 

Delaware		0-16469		13-3275609
(State or other jurisdiction of incorporation or organization)		Commission File Number		(I.R.S. Employer Identification No.)

 

551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)

 

212.983.2640
(Registrant’s Telephone number, including area code)

 

   (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $.001 par value per share		IPAR		The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

 

Certain portions of our press release dated May 5, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

• The 1^st, 2^nd (consisting of a table), 3^rd through 7^th and 11 through 14^th and 16^th through 18^th full paragraphs relating to results of operations for the first quarter of 2026
• Portion of the 15^th paragraph relating to advertising and promotional expense for the first quarter of 2026
• The 9^th paragraph relating to the Company’s ESG rating increase
• The 19^th paragraph relating to balance sheet items, cash flow, inventory and long-term debt
• The 23^rd through 26^th paragraphs relating to the conference call scheduled for May 6, 2026
• The consolidated statements of income and consolidated balance sheets
  

Item 7.01 Regulation FD Disclosure

 

Certain portions of our press release dated May 5, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

• The 8^th paragraph relating to the Company’s portfolio of future innovation pipelines, including new blockbusters and product extension lines for the remainder of the year and 2027
• The 10^th paragraph relating to the Company’s cautious optimism pertaining to the fragrance market and Company's portfolio
• Part of the 15^th paragraph relating to the Company’s future product launches in 2027
• The 20^th and 21^st paragraphs relating to reaffirmance of the previously announced 2026 guidance for the Company
• The 29^th paragraph relating to forward-looking information
• The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 8.01 Other Events

• The 22^nd paragraph relating to dividends
  

Item 9.01 Financial Statements and Exhibits.

 

99.1	Our press release dated May 5, 2026

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

 

Dated: May 5, 2026

 

	Interparfums, Inc.
	By:	/s/ Michel Atwood
		Michel Atwood,
		Chief Financial Officer